Biography
Dr. Palmer is a cancer epidemiologist based at the Slone Epidemiology Center, with research projects spanning cancer early detection, etiology, and survivorship. Her primary focus is on elucidating reasons for the disproportionately high incidence of hormone receptor negative breast cancer in U.S. Black women and on understanding and reducing racial disparities in breast cancer mortality. She is a founding leader of the Black Women’s Health Study (BWHS), a prospective cohort study of 59,000 self-identified Black women who enrolled in 1995 and have been followed by biennial questionnaire since that time. Her breast cancer research within the BWHS includes work on risk prediction models for breast cancer in U.S. Black women, identifying differences in childbearing patterns as a contributing cause to the excess incidence of estrogen receptor negative breast cancer in Black women, and investigating the interrelationships of type 2 diabetes, obesity, and inflammation on breast cancer risk. Her current grants support work on somatic mutations, epigenetics, and gene expressions profiles in breast cancer tumors from African American women, setting the stage for a better understanding of the role of epidemiologic and genetic factors in etiology and prognosis. Dr. Palmer has served on many NIH and external advisory committees, including as Chair of the NIH Cancer, Cardiovascular, and Sleep Epidemiology Study Section, 2015-2017, and Co-Chair of a Working Group for the National Cancer Advisory Board, NCI, 2018-2019. Dr. Palmer was awarded the AACR Distinguished Lectureship on the Science of Cancer Health Disparities in 2017. She has served as a Komen Scholar since 2018 and as a Breast Cancer Research Foundation Investigator since 2023.